USP11 and diffuse large B-cell lymphoma: Our observation that depletion of USP11 or inhibition using a non-specific inhibitor such as Mitoxantrone significantly reduces DLBCL proliferation further supports the need for the development of USP11-specific inhibitors for targeting DLBCL.